Recicort vet.

1 x 20 ml

Ear drops, solution

Active substance

Salicylic acid : 17,7 mg/ml

Triamcinolone (Triamcinolone acetonide) : 1,77 mg/ml

ATC code

QD07XB02 Triamcinolone (Corticosteroids - moderately potent (group II))

QD07XB Corticosteroids - moderately potent (group II)) other comb.

QD07X Corticosteroids, other comb.

QD07 Corticosteroids, dermatological preparations

QD Dermatologicals

Species

Dogs and cats.

Indications

Treatment of otitis externa.
Symptomatic treatment of seborrhoeic dermatitis of the auricle.

Dose to be administered and administration route

For ear and cutaneous (auricle) use.

Ear canal
Clean the external ear canal and auricle. The recommended treatment dose is 8-10 drops instilled into the affected external ear canal(s), once or twice daily. Massage the ear and the auditory canal thoroughly yet gently to ensure proper distribution of the product.
The treatment dose (8-10 drops per ear; once or twice daily) should not exceed 7 drops per kg bodyweight per day. Care should be taken not to exceed this amount, particularly when treating smaller animals or when both ears require treatment. Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms but no longer than 14 days. If the otitis externa does not improve after 3 days of treatment the treatment should be re-evaluated.

Auricle
For the treatment of auricular seborrhoeic dermatitis, apply twice a day a sufficient number of drops onto the auricular surface so that when spread, the affected area is covered. If necessary, rub the area gently to ensure the veterinary medicinal product reaches all the affected skin. Let dry. In severe cases the effect can be increased by applying a second and third layer immediately after the drying of the first layer provided that the total number of applied drops does not exceed the maximum dose of 7 drops per kg body weight per day. Care should be taken not to exceed this dose when treating smaller dogs and cats.
Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms but no longer than 14 days.

Adverse reactions

Dogs and cats:

Rare

(1 to 10 animals / 10,000 animals treated)

Application site reddening, Application site skin scaling

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Skin thinning^a

Suppression of adrenal function^a,b

Undetermined frequency (cannot be estimated from the available data)

Delayed healing^a

^a Local and systemic effects are known to be triggered with prolonged and extensive use of topical corticosteroid preparations.

^b Undetermined frequency for target species cat. Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.